Novartis AG (NYSE:NVS) is one of the stocks that was recently put under the microscope by Jim Cramer. During the lightning round, a caller asked if they should buy, sell, or hold the stock. In response, Cramer said, “Oh, come on, Vas [CEO Vasant (Vas) Narasimhan] is a winner… I’m a buyer of Novartis.” lucarista/Shutterstock.com Novartis AG (NYSE:NVS) develops, manufactures, and markets prescription medicines across cardiovascular, immunology, neuroscience, oncology, and hematology areas. Loomis Sayles s ...